These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34306269)
21. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder. Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804 [TBL] [Abstract][Full Text] [Related]
22. Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis. Newcomer JW; Ng-Mak D; Rajagopalan K; Loebel A BMC Health Serv Res; 2018 Apr; 18(1):243. PubMed ID: 29618351 [TBL] [Abstract][Full Text] [Related]
23. Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics. Yunusa I; Teng C; Karaye IM; Crounse E; Alsahali S; Maleki N Front Psychiatry; 2022; 13():917351. PubMed ID: 35733796 [TBL] [Abstract][Full Text] [Related]
24. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis. Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767 [TBL] [Abstract][Full Text] [Related]
25. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis. Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635 [TBL] [Abstract][Full Text] [Related]
26. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. Gianfrancesco FD; Rajagopalan K; Sajatovic M; Wang RH J Clin Psychiatry; 2006 Feb; 67(2):222-32. PubMed ID: 16566617 [TBL] [Abstract][Full Text] [Related]
27. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Maher AR; Theodore G J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311 [TBL] [Abstract][Full Text] [Related]
29. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study. Pae CU; Nassir Ghaemi S; Patkar A; Chae JH; Bahk WM; Jun TY; Masand P Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1322-5. PubMed ID: 16631294 [TBL] [Abstract][Full Text] [Related]
30. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734 [TBL] [Abstract][Full Text] [Related]
31. Cost analysis in a Medicaid program for patients with bipolar disorder who initiated atypical antipsychotic monotherapy. Qiu Y; Christensen DB; Fu AZ; Liu GG Curr Med Res Opin; 2009 Feb; 25(2):351-61. PubMed ID: 19192979 [TBL] [Abstract][Full Text] [Related]
32. Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy. Nadkarni A; Kalsekar I; You M; Forbes R; Hebden T Clinicoecon Outcomes Res; 2013; 5():49-57. PubMed ID: 23378778 [TBL] [Abstract][Full Text] [Related]
33. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder. Seetasith A; Greene M; Hartry A; Burudpakdee C J Med Econ; 2018 Sep; 21(9):888-901. PubMed ID: 29862860 [TBL] [Abstract][Full Text] [Related]
34. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study. Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159 [TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Miller DS; Yatham LN; Lam RW J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879 [TBL] [Abstract][Full Text] [Related]
36. Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US. O'Day K; Rajagopalan K; Meyer K; Pikalov A; Loebel A Clinicoecon Outcomes Res; 2013; 5():459-70. PubMed ID: 24049452 [TBL] [Abstract][Full Text] [Related]
37. Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine. Huang H; Schmerold L; Dembek C; Fan Q; Dieyi C; Williams GR; Loebel A J Med Econ; 2021; 24(1):352-362. PubMed ID: 33588674 [TBL] [Abstract][Full Text] [Related]
38. Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis. Lindström L; Lindström E; Nilsson M; Höistad M J Affect Disord; 2017 Apr; 213():138-150. PubMed ID: 28222360 [TBL] [Abstract][Full Text] [Related]
39. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat. Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955 [TBL] [Abstract][Full Text] [Related]